Stiefel Can't Shake ERISA, Fraud Claims Over GSK Buy

Law360, New York (January 18, 2012, 5:42 PM EST) -- A Florida federal judge on Tuesday shot down Stiefel Laboratories Inc.’s bid to toss a lawsuit alleging it tricked a former sales representative into selling Stiefel shares back to the company at artificially low prices before it was bought by GlaxoSmithKline PLC.

In a one-page ruling, U.S. District Judge James Lawrence King denied Stiefel’s motion for summary judgment on Employee Retirement Income Security Act and securities fraud claims brought by Timothy Finnerty, the only remaining plaintiff in what was once a putative class action. The ruling...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.